Genetic Technologies Stock Price Prediction
| GENE Stock | USD 2.39 0.02 0.84% |
Oversold Vs Overbought
61
Oversold | Overbought |
Genetic Technologies stock price prediction is an act of determining the future value of Genetic Technologies shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Genetic Technologies' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Genetic Technologies and does not consider all of the tangible or intangible factors available from Genetic Technologies' fundamental data. We analyze noise-free headlines and recent hype associated with Genetic Technologies, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Genetic Technologies' stock price prediction:Wall Street Target Price 12.5 | Quarterly Revenue Growth (0.02) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Genetic Technologies based on different types of headlines from major news networks to social media. The Genetic stock price prediction module provides an analysis of price elasticity to changes in media outlook on Genetic Technologies over a specific investment horizon. Using Genetic Technologies hype-based prediction, you can estimate the value of Genetic Technologies from the perspective of Genetic Technologies response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Genetic Technologies using Genetic Technologies' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Genetic using crowd psychology based on the activity and movement of Genetic Technologies' stock price.
Genetic Technologies Implied Volatility | 176.86 |
Genetic Technologies' implied volatility exposes the market's sentiment of Genetic Technologies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Genetic Technologies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Genetic Technologies stock will not fluctuate a lot when Genetic Technologies' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Genetic Technologies. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Genetic Technologies to buy its stock at a price that has no basis in reality. In that case, they are not buying Genetic because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Genetic Technologies after-hype prediction price | USD 2.31 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Genetic |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Genetic Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Genetic Technologies After-Hype Price Prediction Density Analysis
As far as predicting the price of Genetic Technologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Genetic Technologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Genetic Technologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Genetic Technologies Estimiated After-Hype Price Volatility
In the context of predicting Genetic Technologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Genetic Technologies' historical news coverage. Genetic Technologies' after-hype downside and upside margins for the prediction period are 0.12 and 7.35, respectively. We have considered Genetic Technologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Genetic Technologies is very risky at this time. Analysis and calculation of next after-hype price of Genetic Technologies is based on 3 months time horizon.
Genetic Technologies Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Genetic Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genetic Technologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Genetic Technologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.34 | 5.04 | 0.08 | 0.05 | 8 Events / Month | 8 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.39 | 2.31 | 3.35 |
|
Genetic Technologies Hype Timeline
Genetic Technologies is currently traded for 2.39. The entity has historical hype elasticity of -0.08, and average elasticity to hype of competition of -0.05. Genetic is estimated to decline in value after the next headline, with the price expected to drop to 2.31. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -3.35%, whereas the daily expected return is currently at 0.34%. The volatility of related hype on Genetic Technologies is about 3500.0%, with the expected price after the next announcement by competition of 2.34. The book value of the company was currently reported as 0.04. The company recorded a loss per share of 0.15. Genetic Technologies last dividend was issued on the 15th of August 2019. The entity had 1:5 split on the 14th of December 2023. Given the investment horizon of 90 days the next estimated press release will be in about 8 days. Check out Genetic Technologies Basic Forecasting Models to cross-verify your projections.Genetic Technologies Related Hype Analysis
Having access to credible news sources related to Genetic Technologies' direct competition is more important than ever and may enhance your ability to predict Genetic Technologies' future price movements. Getting to know how Genetic Technologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Genetic Technologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NUVB | Nuvation Bio | 0.70 | 9 per month | 3.98 | 0.14 | 16.67 | (6.50) | 46.16 | |
| LYEL | Lyell Immunopharma | 0.29 | 7 per month | 5.60 | 0.07 | 9.62 | (8.57) | 35.33 | |
| IPSC | Century Therapeutics | (0.24) | 9 per month | 0.00 | (0.05) | 8.37 | (9.48) | 32.09 | |
| GBIO | Generation BioCo | (0.15) | 7 per month | 4.68 | 0.13 | 9.85 | (7.51) | 34.39 | |
| STTK | Shattuck LabsInc | (0.20) | 8 per month | 3.24 | 0.03 | 9.31 | (5.43) | 19.00 | |
| FHTX | Foghorn TherapeuticsInc | 0.13 | 10 per month | 5.97 | 0.06 | 22.68 | (10.50) | 69.93 | |
| GLUE | Monte Rosa Therapeutics | 0.32 | 7 per month | 7.15 | 0.04 | 10.84 | (9.52) | 38.28 | |
| KYMR | Kymera Therapeutics | (1.28) | 10 per month | 2.60 | 0.1 | 5.99 | (4.38) | 16.10 | |
| NRIX | Nurix TherapeuticsInc | (0.98) | 9 per month | 3.66 | 0.14 | 9.80 | (6.94) | 36.91 | |
| KZR | Kezar Life Sciences | (0.03) | 8 per month | 3.02 | (0.01) | 7.61 | (5.81) | 19.42 |
Genetic Technologies Additional Predictive Modules
Most predictive techniques to examine Genetic price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Genetic using various technical indicators. When you analyze Genetic charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Genetic Technologies Predictive Indicators
The successful prediction of Genetic Technologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Genetic Technologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Genetic Technologies based on analysis of Genetic Technologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Genetic Technologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Genetic Technologies's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 130.06 | 80.75 | 72.68 | 69.04 | PTB Ratio | 47.74 | 56.99 | 51.29 | 39.42 |
Story Coverage note for Genetic Technologies
The number of cover stories for Genetic Technologies depends on current market conditions and Genetic Technologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Genetic Technologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Genetic Technologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Genetic Technologies Short Properties
Genetic Technologies' future price predictability will typically decrease when Genetic Technologies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Genetic Technologies often depends not only on the future outlook of the potential Genetic Technologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genetic Technologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 101.4 M | |
| Cash And Short Term Investments | 7.9 M |
Check out Genetic Technologies Basic Forecasting Models to cross-verify your projections. For information on how to trade Genetic Stock refer to our How to Trade Genetic Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Genetic Stock analysis
When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Genetic Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genetic Technologies. If investors know Genetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genetic Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 2.73 | Quarterly Revenue Growth (0.02) | Return On Assets (0.53) | Return On Equity (1.60) |
The market value of Genetic Technologies is measured differently than its book value, which is the value of Genetic that is recorded on the company's balance sheet. Investors also form their own opinion of Genetic Technologies' value that differs from its market value or its book value, called intrinsic value, which is Genetic Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genetic Technologies' market value can be influenced by many factors that don't directly affect Genetic Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genetic Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Genetic Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genetic Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.